STAT4 and metastatic malignant neoplasm: However, given that serum IL-12 levels are significantly lower in metastatic cancer patients compared to non-metastatic patients (44), it is possible that the diminished IL-12 production potentially contributes to the increased metastasis observed in tumor bearing Stat4−/− mice.